Taking 250 mg of potassium daily for two months raises melatonin and lowers cortisol in people with diabetes, which are hormones that help regulate sleep cycles.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A meta-analysis of RCTs would determine whether potassium supplementation consistently alters melatonin and cortisol in diabetic populations, independent of magnesium.
A systematic review and meta-analysis of all double-blind RCTs evaluating potassium (100–300 mg/day) in adults with type 2 diabetes, reporting pre- and post-intervention serum melatonin and cortisol levels, with standardized ELISA methods and adjustment for HbA1c, renal function, and baseline electrolyte status.
A double-blind RCT would confirm whether potassium alone, without magnesium, reliably alters melatonin and cortisol in diabetic patients.
A double-blind RCT with 120 diabetic participants randomized to 250 mg potassium chloride, 250 mg magnesium gluconate, both, or placebo for 8 weeks, with serum melatonin and cortisol measured at 0, 4, and 8 weeks under standardized light/dark conditions and fasting, while controlling for depression and sleep hygiene.
A cohort study would determine whether higher dietary potassium intake predicts sustained changes in melatonin and cortisol rhythms over time in diabetic individuals.
A prospective cohort study following 500 diabetic adults for 2 years, measuring dietary potassium intake quarterly and serum melatonin/cortisol levels semi-annually, with actigraphy to assess sleep-wake cycles and adjustment for medication and mental health.
A case-control study would determine whether diabetic patients with low melatonin levels have significantly lower potassium intake or serum levels than those with normal melatonin.
A case-control study comparing serum potassium and melatonin levels in 100 diabetic patients with low melatonin (<15 pg/mL) and 100 with normal melatonin (>25 pg/mL), matched for age, sex, HbA1c, and sleep duration.
A cross-sectional study would identify whether serum potassium levels correlate with melatonin and cortisol concentrations in diabetic patients at a single time point.
A cross-sectional analysis of 800 diabetic patients measuring serum potassium, melatonin, and cortisol levels in a single visit under standardized conditions, with adjustment for BMI, HbA1c, and time of blood draw.